• Profile
Close

Substance P (SP) and neurokinin 1 receptor (NK1R) are new targets for the treatment of chronic pruritus

British Journal of Dermatology Apr 27, 2019

Stander S, et al. - The pathogenesis of chronic pruritus, centering the role of substance P (SP) and neurokinin 1 receptor (NK1R) in itch signaling was estimated to illustrate NK1R antagonism as a likely approach for the treatment of chronic pruritus. Investigators observed NK1R expression in the central nervous system and on multiple cell types, involved in the initiation and transmission of itch. Disruption of NK1R antagonism in itch signaling reduced the itch and acted as a potential treatment of chronic pruritus across multiple diseases. It was also noted that SP and NK1R were overexpressed across multiple chronic itch-inducing conditions.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay